Chinese yeast factory boosts cancer drug production speed 1,000 times

Scientists have transformed ordinary yeast into a highly efficient factory for a crucial cancer drug, dramatically accelerating production speed by a factor of 1,000. The breakthrough comes from a research team at Zhejiang University in China.

The drug, vinblastine, is vital in treating various cancers. Historically, it has been exclusively extracted from the Madagascar periwinkle plant. This natural source presents significant limitations: producing just one gram of vinblastine requires two tonnes of dried plant leaves. This scarcity makes the drug exceptionally expensive, often costing more than gold by weight, and leads to an unreliable supply chain.

By genetically modifying yeast, the researchers have overcome these production hurdles. This innovative approach not only boosts the speed of synthesis but also offers a more sustainable and potentially cost-effective method for manufacturing vinblastine. The development could make this life-saving medication more accessible to patients worldwide, addressing long-standing issues of high cost and supply instability.